Table 1.

Patient data

Patient	Sex/Age/Disease Duration, (M/F)/yr/yr	Epilepsy Syndrome	Etiology	Seizure Lateralization	Seizure Onset	Antiepileptic Drug	Surface EEG Channel, resting state/task
P1	M/39/9	Multifocal	Cryptogenic	Bilateral	Bifrontal	LCM (400 mg), ZNS (400 mg)	FCz, Cz/Oz, Fpz, Cz
P2	M/32/31	Multifocal	Genetic (SCNA1)	Left, possibly bilateral	Bifrontal and left mediotemporal	OXC (900 mg), clobazam 5 mg), STP (4,500 mg)	T1, T2, Fpz, Oz, Cz/Oz, Fpz, Cz, POz
P3	F/44/14	Multifocal	Right hippocampal sclerosis*	Bilateral	Temporal	CBZ (1,200 mg)	Oz, Fpz, Cz/Oz, Fpz, Cz
P4	M/40/31	Focal	Left hippocampal sclerosis†	Left	Temporal	LTG (400 mg), LCM (400 mg)	Oz, Fpz, Cz/Oz, Fpz, Cz
P5	F/28/12	Multifocal	Cryptogenic	Bilateral	Temporal	LTG (200 mg, LCM (200 mg)	Fpz, Cz/no task data
P6	F/52/17	Focal	Cryptogenic	Left	Temporal	LTG (250 mg), LCM (400 mg)	No resting-state data/Oz, Fpz, Cz

M/F, male/female; LCM, lacosamide; ZNS, zonisamide; OXC, oxcarbazepine; STP, stiripentol; CBZ, carbamazepine; LTG, lamotrigine.

^*P3 underwent right temporal lobe resection 3 yr before deep brain stimulation (DBS) surgery.

^†P4 underwent left temporal lobe resection 9 yr before DBS surgery.